Nuclein’s DASH SARS-CoV-2 & Flu A/B Test, which is designed for use with the DASH Rapid PCR System, has gained the US Food ...
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug ...
SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly ...
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
AEye, Inc. , a global leader in adaptive, high-performance lidar solutions, today announced an update on 4Sight'stm record-breaking, behind-the-windshield performance. AEye CEO Matt Fisch said, "Our ...
JLab, a leading personal technology and audio brand, is excited to announce their second content series for the 2024 - 2025 ...
VIV Health is thrilled to announce the upcoming launch of the VIV™ Ring, the world's first smart ring equipped with Generative Sleep aid sound, at CES 2025, starting January 7. This innovative device ...
NEW YORK – In 2024, firms in the sepsis testing space made big moves to begin or expand the commercialization of tests that could help reduce the time-to-results, while many also secured funding to ...